Oncology
Economist Brussels Day 2

9th Annual World Cancer Series: Day 2

As Economist Impact’s World Cancer Series continues, Day Two firmly takes up focus on the patient voice, with a presentation by Eileen Page, chief executive of Innovation Advantage 2020 to

Featured Content

R&D
pharmaphorum podcast episode 98

Turning drug development on its head

Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho

Oncology
Greg Deener at CAR-TCR

CAR-TCR 2023 – Greg Deener

In late August, pharmaphorum traveled to Boston to cover CAR-TCR, a conference dedicated to the fast-moving cell therapy space.

Editor's Picks

  1. FTC fires shot across pharma's bows over 'improper' patents
  2. Scientists find elusive cause of cell death in Alzheimer's
  3. UK trial will test digital tinnitus therapy from Oto
  4. Vydura is first NICE-backed oral GPCR for acute migraine
  5. Pitango partner talks new $175M health tech fund, AI, and rocky markets

Newsletters and Deep Dive
digital magazine

Latest News

Views & Analysis

Oncology
Economist Brussels Day 2

9th Annual World Cancer Series: Day 2

As Economist Impact’s World Cancer Series continues, Day Two firmly takes up focus on the patient voice, with a presentation by Eileen Page, chief executive of Innovation Advantage 2020 to

Deep Dive

Sales & Marketing
Celebrating 75 Years of the NHS: A timeline

Celebrating 75 Years of the NHS: A timeline

Since its inception in 1948, the National Health Service (NHS) has played a crucial role in providing accessible healthcare to millions in the United Kingdom.

White Papers & Webinar

Sales & Marketing
Coaching Never Sleeps
Sponsored

Coaching Never Sleeps

Coaching has developed into one of the most powerful tools in a fast-changing pharmaceutical sector.

Podcasts & Video

R&D
pharmaphorum podcast episode 98

Turning drug development on its head

Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho

Oncology
Greg Deener at CAR-TCR

CAR-TCR 2023 – Greg Deener

In late August, pharmaphorum traveled to Boston to cover CAR-TCR, a conference dedicated to the fast-moving cell therapy space.

Partner Content

R&D
2nd Innate Killer Europe Summit
Partner Content

2nd Innate Killer Europe Summit

The 2nd Innate Killer Europe Summit will gather 80+ key European Gamma Delta T, NK, iNKT, neutrophil, and macrophage developers in October to chase the holy grail of efficacious, off-the-sh

R&D
3rd Synthetic Biology-Based Therapeutics Summit
Partner Content

3rd Synthetic Biology-Based Therapeutics Summit

The 3rd Synthetic Biology-Based Therapeutics Summit is a platform uniting academia, engineers, and drug developers working towards increased specificity, durability and potency.